Aspira Pathlab Schedules September 12 Board Meeting To Consider Fundraising

Board meeting on September 12, 2026 will evaluate fundraising through equity shares, warrants, preferential issue, private placement, rights issue, or other permitted methods, subject to approvals. No amount, pricing, purpose, or instrument has been specified; this revisits the fundraising proposal deferred in August.